S

Sapphire Pharmaceuticals (Europe) (Private limited company)

BE 0649.580.096 Active ●De Linde 107, 8310 Bruges

Sapphire Pharmaceuticals (Europe) is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 0649.580.096. It was founded on 03-03-2016. Its registered office is in Bruges. Its main activity is: Wholesale trade. Its annual accounts for 2025 report equity of € 26 802 and a loss of € 104 413. Addrly gives it a financial health grade of E, on a scale from A (safest) to E (most at risk). It filed its annual accounts within the legal deadline for 0 of its last 4 financial years.

Information last updated on 10-10-2026.

Company information

Status
Active
Enterprise number
BE 0649.580.096
VAT registered
Yes
Founded
03-03-2016
Latest accounts
2025
Employees
-
Region
Flanders
Establishments
1
Filing record
Late for 2022, 2023, 2024, 2025
Peppol e-invoicing
Registered
Registered office
De Linde 107, 8310 Bruges
Main activity
Wholesale trade
NACE activities
46500 Commerce de gros d’équipements de l’information et de la communication
46851 Commerce de gros de produits chimiques à usage industriel
47730 Commerce de détail de produits pharmaceutiques
47741 Commerce de détail d'articles médicaux et orthopédiques, à l'exception de lunettes de correction, de lentilles et de lunettes de soleil

Key figures of Sapphire Pharmaceuticals (Europe)

2025202420232022
Profit / loss
iWhat the period earned after taxes. A negative amount is a loss.
€ -104 413€ 275 738€ -48 590-38 %€ -35 297
Equity
iWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company.
€ 26 802-80 %€ 131 215€ -144 523-51 %€ -95 934
Total assets
iEverything the company owns. Equal to total equity and liabilities, which says how it is financed.
€ 53 551-80 %€ 262 473+165 %€ 98 930+5 %€ 94 203
Gross margin
iSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else.
€ -68 177€ 277 492€ -45 245-38 %€ -32 747
Employees (FTE)
iAverage number of workers over the period, in full-time equivalents.
----

Financial estimate

Financial health grade E, on a scale from A (safest) to E (most at risk)
Health barometer
The failure probability and the indicators behind this grade are visible with a free account.
Create a free account
Illustrative preview
Detected events
Appointments, capital, registered office, proceedings, extracted from the official acts.
Create a free account
Illustrative preview
Directors & mandates
1 mandate on record in the annual accounts.
Create a free account

Similar companies

Other companies in the same activity in Bruges.

CompanyTown
COLOMBINE 8310 Brugge
MY SPECTRUM 8310 Brugge
DAENENS JOBS & INTERIM 8310 Brugge
Lecomte Karel 8310 Brugge
B7 8310 Brugge
KRIS VAN DE WEGHE 8310 Brugge
Maroli 8310 Brugge
Vervoeronderneming Gustave Snauwaert en zonen 8310 Brugge
Looking for more information about Sapphire Pharmaceuticals (Europe)?
The free plan gives you 20 complete company dossiers every month, no card required: health barometer, directors, company links and detected events.
Create a free account

Frequently asked questions

Is Sapphire Pharmaceuticals (Europe) still active? Yes. The Crossroads Bank for Enterprises lists Sapphire Pharmaceuticals (Europe) as active.

What is the VAT number of Sapphire Pharmaceuticals (Europe)? The VAT number of Sapphire Pharmaceuticals (Europe) is BE 0649.580.096.

When was Sapphire Pharmaceuticals (Europe) founded? Sapphire Pharmaceuticals (Europe) was founded on 03-03-2016.

What is the address of Sapphire Pharmaceuticals (Europe)? The current registered office of Sapphire Pharmaceuticals (Europe) is De Linde 107, 8310 Bruges.

When did Sapphire Pharmaceuticals (Europe) last file annual accounts? The latest annual accounts of Sapphire Pharmaceuticals (Europe) were filed on 29-09-2026.

Does Sapphire Pharmaceuticals (Europe) file its annual accounts on time? Sapphire Pharmaceuticals (Europe) filed its annual accounts within the legal deadline for 0 of its last 4 financial years. Late: 2022, 2023, 2024, 2025.

Is Sapphire Pharmaceuticals (Europe) financially healthy? Addrly gives Sapphire Pharmaceuticals (Europe) a financial health grade of E, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.

Is Sapphire Pharmaceuticals (Europe) profitable? The annual accounts of Sapphire Pharmaceuticals (Europe) for 2025 show a loss of € 104 413.

What is the equity of Sapphire Pharmaceuticals (Europe)? The equity of Sapphire Pharmaceuticals (Europe) was € 26 802 at the close of the 2025 financial year.

Who are the directors of Sapphire Pharmaceuticals (Europe)? The annual accounts of Sapphire Pharmaceuticals (Europe) record 1 mandate. The name, role and dates are visible with a free account.

Can Sapphire Pharmaceuticals (Europe) receive Peppol e-invoices? Yes. Sapphire Pharmaceuticals (Europe) is registered on the Peppol network and can receive structured electronic invoices.

What does Sapphire Pharmaceuticals (Europe) do? The main activity of Sapphire Pharmaceuticals (Europe) is: Wholesale trade.

Sources

How Addrly builds and refreshes this data